PALISADE CAPITAL MANAGEMENT, LP Q3 2019 Filing

Filed November 6, 2019

Portfolio Value

$3.3B

Holdings

425

Report Date

Q3 2019

Filing Type

13F-HR

All Holdings (425 positions)

#	Stock	Shares	Value	% Portfolio
401	ABTABBOTT LABS	2,850	$238K	0.01%
402	GILDGILEAD SCIENCES INC	3,650	$231K	0.01%
403	—SYNCHRONOSS TECHNOLOGIES INC	42,800	$231K	0.01%
404	PEGPUBLIC SVC ENTERPRISE GRP IN	3,700	$230K	0.01%
405	FDXFEDEX CORP	1,500	$218K	0.01%
406	VTYVERINT SYS INC	5,000	$214K	0.01%
407	MTGMGIC INVT CORP WIS	16,600	$209K	0.01%
408	MOHMOLINA HEALTHCARE INC	1,900	$208K	0.01%
409	AVTRAVANTOR INC	13,784	$203K	0.01%
410	DEODIAGEO P L C	1,235	$202K	0.01%
411	YORWYORK WTR CO	4,600	$201K	0.01%
412	—TIVO CORP	25,000	$190K	0.01%
413	FEYECHFFIREEYE INC	14,000	$187K	0.01%
414	—RETROPHIN INC	13,502	$156K	0.00%
415	GEGENERAL ELECTRIC CO	17,000	$152K	0.00%
416	—CLOVIS ONCOLOGY INC	330,000	$139K	0.00%
417	SDCCQSMILEDIRECTCLUB INC	10,000	$139K	0.00%
418	—COLONY CAP INC NEW	19,607	$118K	0.00%
419	—DERMIRA INC	11,599	$74K	0.00%
420	CLVSEURCLOVIS ONCOLOGY INC	18,100	$71K	0.00%
421	CXCEMEX SAB DE CV	10,000	$39K	0.00%
422	—NANTHEALTH INC	41,000	$29K	0.00%
423	SENS1GBPSENSEONICS HLDGS INC	25,000	$25K	0.00%
424	—PALATIN TECHNOLOGIES INC	19,010	$17K	0.00%
425	—ENCORE CAP GROUP INC	15,000	$15K	0.00%

PreviousPage 5 of 5